Additional materials of the author at
CSHL Institutional Repository

Amit, Moran, Anastasaki, Corina, Dantzer, Robert, Demir, Ihsan Ekin, Deneen, Benjamin, Dixon, Karen O, Egeblad, Mikala, Gibson, Erin M, Hervey-Jumper, Shawn L, Hondermarck, Hubert, Magnon, Claire, Monje, Michelle, Na'ara, Shorook, Pan, Yuan, Repasky, Elizabeth A, Scheff, Nicole N, Sloan, Erica K, Talbot, Sebastien, Tracey, Kevin J, Trotman, Lloyd C, Valiente, Manuel, Van Aelst, Linda, Venkataramani, Varun, Venkatesh, Humsa S, Vermeer, Paola D, Winkler, Frank, Wong, Richard J, Gutmann, David H , Borniger, Jeremy C (2024) Next Directions in the Neuroscience of Cancers Arising outside the CNS. Cancer Discovery, 14(4) pp. 669-673.

Colucci, Manuel, Zumerle, Sara, Bressan, Silvia, Gianfanti, Federico, Troiani, Martina, Valdata, Aurora, D'Ambrosio, Mariantonietta, Pasquini, Emiliano, Varesi, Angelica, Cogo, Francesca, Mosole, Simone, Dongilli, Cristina, Desbats, Maria Andrea, Contu, Liliana, Revankdar, Ajinkya, Chen, Jingjing, Kalathur, Madhuri, Perciato, Maria Luna, Basilotta, Rossella, Endre, Laczko, Schauer, Stefan, Othman, Alaa, Guccini, Ilaria, Saponaro, Miriam, Maraccani, Luisa, Bancaro, Nicolò, Lai, Ping, Liu, Lei, Pernigoni, Nicolò, Mele, Federico, Merler, Sara, Trotman, Lloyd C, Guarda, Greta, Calì, Bianca, Montopoli, Monica , Alimonti, Andrea (2024) Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells. Cancer Cell, pp. S1535-6108(24)00048.

M. Swamynathan, Manojit, Mathew, Grinu, Aziz, Andrei, Gordon, Chris, Hillowe, Andrew, Wang, Hehe, Jhaveri, Aashna, Kendall, Jude, Cox, Hilary, Giarrizzo, Michael, Azabdaftari, Gissou, Rizzo, Robert C, Diermeier, Sarah D, Ojima, Iwao, Bialkowska, Agnieszka B, Kaczocha, Martin , Trotman, Lloyd C (2024) FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer. Cancers, 16(1) pp. 60-60.

Brina, Daniela, Ponzoni, Adele, Troiani, Martina, Calì, Bianca, Pasquini, Emiliano, Attanasio, Giuseppe, Mosole, Simone, Mirenda, Michela, D'Ambrosio, Mariantonietta, Colucci, Manuel, Guccini, Ilaria, Revandkar, Ajinkya, Alajati, Abdullah, Tebaldi, Toma, Donzel, Deborah, Lauria, Fabio, Parhizgari, Nahjme, Valdata, Aurora, Maddalena, Martino, Calcinotto, Arianna, Bolis, Marco, Rinaldi, Andrea, Barry, Simon, Rüschoff, Jan Hendrik, Sabbadin, Marianna, Sumanasuriya, Semini, Crespo, Mateus, Sharp, Adam, Yuan, Wei, Grinu, Mathew, Boyle, Alexandra, Miller, Cynthia, Trotman, Lloyd, Delaleu, Nicolas, Fassan, Matteo, Moch, Holger, Viero, Gabriella, de Bono, Johann , Alimonti, Andrea (2023) The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. Nature Cancer, 4(8) pp. 1102-1121.

Chung, Taemoon, Garcia, Libia, Swamynathan, Manojit M, Froeling, Fieke EM, Trotman, Lloyd C, Tuveson, David A , Lyons, Scott K (2023) Internally Controlled and Dynamic Optical Measures of Functional Tumor Biology. Analytical Chemistry, 95(13) pp. 5661-5670.

Hillowe, Andrew, Gordon, Chris, Wang, Liqun, Rizzo, Robert C, Trotman, Lloyd C, Ojima, Iwao, Bialkowska, Agnieszka , Kaczocha, Martin (2023) Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells. Pizzo, Salvatore V (Ed.). PLoS One, 18(10) pp. e0292483.

Aakula, Anna, Isomursu, Aleksi, Rupp, Christian, Erickson, Andrew, Gupta, Nikhil, Kauko, Otto, Shah, Pragya, Padzik, Artur, Pokharel, Yuba Raj, Kaur, Amanpreet, Li, Song-Ping, Trotman, Lloyd, Taimen, Pekka, Rannikko, Antti, Lammerding, Jan, Paatero, Ilkka, Mirtti, Tuomas, Ivaska, Johanna , Westermarck, Jukka (2022) PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers. Molecular Oncology,

Chung, Taemoon, Garcia, Libia, Swamynathan, Manojit M, Froeling, Fieke EM, Trotman, Lloyd C, Tuveson, David A , Lyons, Scott K (2022) Internally-controlled and dynamic optical measures of functional tumor biology. biorxiv,

Taranda, Julian, Mathew, Grinu, Watrud, Kaitlin, El-Amine, Nour, Lee, Matthew F, Elowsky, Corey, Bludova, Anastasiia, Escobar Avelar, Sintia, Nowak, Dawid G, Wee, Tse-Luen, Wilkinson, John E, Trotman, Lloyd C , Osten, Pavel (2021) Combined whole-organ imaging at single-cell resolution and immunohistochemical analysis of prostate cancer and its liver and brain metastases. Cell Reports, 37(7) pp. 110027.

Lyons, Scott K, Plenker, Dennis , Trotman, Lloyd C (2021) Advances in preclinical evaluation of experimental antibody-drug conjugates. Cancer Drug Resistance, 4 pp. 745-754.

Oni, T. E., Biffi, G., Baker, L. A., Hao, Y., Tonelli, C., Somerville, T. D. D., Deschênes, A., Belleau, P., Hwang, C. I., Sánchez-Rivera, F. J., Cox, H., Brosnan, E., Doshi, A., Lumia, R. P., Khaledi, K., Park, Y., Trotman, L. C., Lowe, S. W., Krasnitz, A., Vakoc, C. R. , Tuveson, D. A. (2020) SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. J Exp Med, 217(9)

Mathew, G. , Trotman, L. C. (2020) Competence against insufficiency: Why are men mostly safe from a rare and deadly prostate cancer?. Journal of Experimental Medicine, 217(6) pp. e20200087. Rockefeller University Press.

Monje, M., Borniger, J., D'Silva, N.J., Deneen, B., Dirks, P.B., Fattahi, F., Frenette, P.S., Garzia, L., Gutmann, D.H., Hanahan, D., Hervey-Jumper, S.L., Hondermarck, H., Hurov, J.B., Kepecs, A., Knox, S.M., Lloyd, A.C., Magnon, C., Saloman, J.L., Segal, R.A., Sloan, E.K., Sun, X., Taylor, M.D., Tracey, K.J., Trotman, L. C., Tuveson, D. A., Wang, T.C., White, R.A. , Winkler, F. (2020) Roadmap for the Emerging Field of Cancer Neuroscience. Cell, 181(2) pp. 219-222.

Lee, M. F. , Trotman, L. C. (2019) PTEN: Bridging Endocytosis and Signaling. Cold Spring Harb Perspect Med,

Carbonetti, G., Converso, C., Clement, T., Wang, C., Trotman, L., Ojima, I. , Kaczocha, M. (2019) Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth. Prostate,

Froeling, F. E. M., Mosur Swamynathan, M., Deschenes, A., Chio, I. I. C., Brosnan, E., Yao, M. A., Alagesan, P., Lucito, M. S., Li, J., Chang, A. Y., Trotman, L. C., Belleau, P., Park, Y., Rogoff, H. A., Watson, J. D. , Tuveson, D. A. (2019) Bioactivation of napabucasin triggers reactive oxygen species-mediated cancer cell death. Clin Cancer Res, 25(23) pp. 7162-7174.

Rupp, C., Isomursu, A., Aakula, A., Erickson, A., Li, S. P., Kaur, A., Shah, P., Pokharel, Y. R., Trottman, L., Lammerding, J., Rannikko, A., Taimen, P., Mirtti, T., Paatero, I., Ivaska, J. , Westermarck, J. K. (2019) Combined inhibition of tumor suppressors PTEN and PP2A drives anoikis resistance and is associated with therapy relapse in prostate cancer. Cancer Research, 79(13S) pp. Meeting Abstract: 3486 .

Nowak, D. G., Katsenelson, K. C., Watrud, K. E., Chen, M., Mathew, G., D'Andrea, V. D., Lee, M. F., Swamynathan, M. M., Casanova-Salas, I., Jibilian, M. C., Buckholtz, C. L., Ambrico, A. J., Pan, C. H., Wilkinson, J. E., Newton, A. C. , Trotman, L. C. (2019) The PHLPP2 phosphatase is a druggable driver of prostate cancer progression. J Cell Biol, 218(6) pp. 1943-1957.

Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., Upadhyay, P., Uyeminami, D. L., Pommier, A., Kuttner, V., Bruzas, E., Maiorino, L., Bautista, C., Carmona, E. M., Gimotty, P. A., Fearon, D. T., Chang, K., Lyons, S. K., Pinkerton, K. E., Trotman, L. C., Goldberg, M. S., Yeh, J. T. , Egeblad, M. (2018) Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science, 361(6409)

D'Andrea, V., Nowak, D., Watrud, K., Ambrico, A., Casanova-Salas, I. , Trotman, L. (2018) The Phlpp2 phosphatase protects Myc and is a target for the prevention of prostate cancer metastasis. Cancer Research, 78(13 S) pp. Abstract: 1097 .

Naguib, A., Mathew, G., Reczek, C. R., Watrud, K., Ambrico, A., Herzka, T., Salas, I. C., Lee, M. F., El-Amine, N., Zheng, W., Di Francesco, M. E., Marszalek, J. R., Pappin, D. J., Chandel, N. S. , Trotman, L. C. (2018) Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells. Cell Rep, 23(1) pp. 58-67.

Alexander, J., Kendall, J., McIndoo, J., Rodgers, L., Aboukhalil, R., Levy, D., Stepansky, A., Sun, G., Chobadjiev, L., Riggs, M., Cox, H., Hakker, I., Nowak, D. G., Laze, J., Llukani, E., Srivastava, A., Gruschow, S., Yadav, S. S., Robinson, B. D., Atwal, G., Trotman, L. C., Lepor, H., Hicks, J. B., Wigler, M. , Krasnitz, A. (2018) Utility of single cell genomics in diagnostic evaluation of prostate cancer. Cancer Res, 78(2) pp. 348-358.

Lee, M., Naguib, A., Trotman, L. C. , El-Amine, N. (2017) Endocytosis and PTEN in Tumor Suppression. Molecular Biology of the Cell, 28(26 ASC) pp. Abstract M257.

Chen, M., Nowak, D. G., Narula, N., Robinson, B., Watrud, K., Ambrico, A., Herzka, T. M., Zeeman, M. E., Minderer, M., Zheng, W., Ebbesen, S. H., Plafker, K. S., Stahlhut, C., Wang, V. M., Wills, L., Nasar, A., Castillo-Martin, M., Cordon-Cardo, C., Wilkinson, J. E., Powers, S., Sordella, R., Altorki, N. K., Mittal, V., Stiles, B. M., Plafker, S. M. , Trotman, L. C. (2017) The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein. J Cell Biol, 216(3) pp. 641-656.

Senturk, S., Shirole, N. H., Nowak, D. G., Corbo, V., Pal, D., Vaughan, A., Tuveson, D. A., Trotman, L. C., Kinney, J. B. , Sordella, R. (2017) Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization. Nat Commun, 8 pp. 14370.

Labbe, D. P., Uetani, N., Vinette, V., Lessard, L., Aubry, I., Migon, E., Sirois, J., Haigh, J., Begin, L. R., Trotman, L. C., Paquet, M. , Tremblay, M. L. (2016) PTP1B deficiency enables the ability of a high fat diet to drive the invasive character of PTEN-deficient prostate cancers. Cancer Res, 76(11) pp. 3130-3135.

Nowak, D. G., Cho, H., Herzka, T., Wang, V. M. Y., Senturk, S., DeMarco, D. V., Ding, D., Fellmann, C., Beinortas, T., Kleinman, D., Watrud, K., Chen, M., Wilkinson, J. E., Castillo-Martin, M., Cordon-Cardo, C., Robinson, B. D. , Trotman, L. C. (2015) Myc drives Pten/ p53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression via Phlpp2. Cancer Research, 75(Supple) pp. Abstract 2258.

Stahlhut, C. E., Watrud, K. E., Ambrico, A. J., Cho, H., Wang, L. L., Qi, J., Cantley, L. C., Bradner, J. , Trotman, L. C. (2015) Myc vs. Akt therapy in RapidCap, a GEM model for metastatic prostate cancer. Cancer Research, 75(Supple) pp. Abstract 2636.

Trotman, L. C., Nowak, D. G., Cho, H., Herzka, T., Watrud, K., DeMarco, D. V., Wang, V. M., Senturk, S., Fellmann, C., Ding, D., Beinortas, T., Kleinman, D., Chen, M., Sordella, R., Wilkinson, J. E., Castillo-Martin, M., Cordon-Cardo, C. , Robinson, B. D. (2015) Myc drives Pten/trp53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression via Phlpp2. Cancer Discovery, 5(6) pp. 636-651.

Cho, Hyejin, Herzka, Tali, Stahlhut, Carlos, Watrud, Kaitlin, Robinson, Brian D. , Trotman, Lloyd C. (2015) Rapid in vivo validation of candidate drivers derived from the PTEN-mutant prostate metastasis genome. Methods, 77-78 pp. 197-204.

Naguib, Adam, Bencze, Gyula, Cho, Hyejin, Zheng, Wu, Tocilj, Ante, Elkayam, Elad, Faehnle, Christopher R, Jaber, Nadia, Pratt, Christopher P, Chen, Muhan, Zong, Wei-Xing, Marks, Michael S, Joshua-Tor, Leemor, Pappin, Darryl J , Trotman, Lloyd C (2015) PTEN Functions by Recruitment to Cytoplasmic Vesicles. Molecular Cell, 58(2) pp. 255-268.

Naguib, A., Bencze, G., Engle, D. D., Chio, II, Herzka, T., Watrud, K., Bencze, S., Tuveson, D. A., Pappin, D. J. , Trotman, L. C. (2014) P53 Mutations Change Phosphatidylinositol Acyl Chain Composition. Cell Reports, 10(1) pp. 8-19.

Reyes, G., Niederst, M., Cohen-Katsenelson, K., Stender, J. D., Kunkel, M. T., Chen, M., Brognard, J., Sierecki, E., Gao, T., Nowak, D. G., Trotman, L. C., Glass, C. K. , Newton, A. C. (2014) Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output. Proc Natl Acad Sci U S A, 111(38) pp. E3957-E3965.

Pulido, R., Baker, S. J., Barata, J. T., Carracedo, A., Cid, V. J., Chin-Sang, I. D., Dave, V., den Hertog, J., Devreotes, P., Eickholt, B. J., Eng, C., Furnari, F. B., Georgescu, M. M., Gericke, A., Hopkins, B., Jiang, X., Lee, S. R., Losche, M., Malaney, P., Matias-Guiu, X., Molina, M., Pandolfi, P. P., Parsons, R., Pinton, P., Rivas, C., Rocha, R. M., Rodriguez, M. S., Ross, A. H., Serrano, M., Stambolic, V., Stiles, B., Suzuki, A., Tan, S. S., Tonks, N. K., Trotman, L. C., Wolff, N., Woscholski, R., Wu, H. , Leslie, N. R. (2014) A Unified Nomenclature and Amino Acid Numbering for Human PTEN. Science signaling, 7(332) pp. pe15.

Chen, M., Nowak, D. G. , Trotman, L. C. (2014) Molecular Pathways: PI3K Pathway Phosphatases as Biomarkers for Cancer Prognosis and Therapy. Clinical Cancer Research, 20(12) pp. 3057-63.

Cho, H., Herzka, T., Zheng, W., Qi, J., Wilkinson, J. E., Bradner, J. E., Robinson, B. D., Castillo-Martin, M., Cordon-Cardo, C. , Trotman, L. C. (2014) RapidCaP, a novel GEM model for analysis and therapy of metastatic prostate cancer, reveals Myc as a driver of Pten-mutant metastasis. Cancer Discovery, 4(3) pp. 318-33.

Labbé, D. P., Nowak, D. G., Deblois, G., Lessard, L., Giguère, V., Trotman, L. C. , Tremblay, M. L. (2014) Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors. Molecular Cancer Research, 12(2) pp. 184-189.

Newton, A. C. , Trotman, L. C. (2014) Turning off AKT: PHLPP as a drug target. Annu Rev Pharmacol Toxicol, 54 pp. 537-58.

Chen, M. H., Herzka, T. M., Zeeman, M. E., Plafker, K. S., Minderer, M., Castillo-Martin, M., Cordon-Cardo, C., Plafker, S. M. , Trotman, L. C. (2013) PTEN levels are controlled by a nuclear transport receptor in lung cancer. Cancer Research, 73(8 (Sup) pp. 5258.

Cho, H. J., Herzka, T., Zheng, W., Castillo-Martin, M., Cordon-Cardo, C. , Trotman, L. C. (2013) Rapid Cap: A new generation of mouse models for prostate cancer. Cancer Research, 73(8 (Sup) pp. 4091.

Naguib, A., Bencze, G., Faehnle, C. R., Schalch, T., Lazar, Z., Ruse, C. I., Joshua-Tor, L., Pappin, D. J. , Trotman, L. C. (2013) Upstream activation of PTEN. Cancer Research, 73(8 (Sup) pp. 5156.

Naguib, A. , Trotman, L. C. (2013) PTEN plasticity: how the taming of a lethal gene can go too far. Trends In Cell Biology, 23(8) pp. 374-379.

Lessard, L., Labbé, D. P., Deblois, G., Beǵin, L. R., Hardy, S., Mes-Masson, A. M., Saad, F., Trotman, L. C., Giguére, V. , Tremblay, M. L. (2012) PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer. Cancer Research, 72(6) pp. 1529-1537.

Xiong, Q., Oviedo, H. V., Trotman, L. C. , Zador, A. M. (2012) PTEN Regulation of Local and Long-Range Connections in Mouse Auditory Cortex. Journal of Neuroscience, 32(5) pp. 1643-52.

Howitt, J., Lackovic, J., Low, L. H., Naguib, A., Macintyre, A., Goh, C. P., Callaway, J. K., Hammond, V., Thomas, T., Dixon, M., Putz, U., Silke, J., Bartlett, P., Yang, B. L., Kumar, S., Trotman, L. C. , Tan, S. S. (2012) Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia. Journal of Cell Biology, 196(1) pp. 29-36.

Chen, M. H., Pratt, C. P., Zeeman, M. E., Schultz, N., Taylor, B. S., O'Neill, A., Castillo-Martin, M., Nowak, D. G., Naguib, A., Grace, D. M., Murn, J., Navin, N., Atwal, G. S., Sander, C., Gerald, W. L., Cordon-Cardo, C., Newton, A. C., Carver, B. S. , Trotman, L. C. (2011) Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression. Cancer Cell, 20(2) pp. 173-186.

Trotman, L. C. (2011) Calling on the cancer sleuths: how cell biologists will do the detective legwork of the postcancer genome era.. Molecular Biology of the Cell, 22(6)

Schreiber, S. L., Shamji, A. F., Clemons, P. A., Hon, C., Koehler, A. N., Munoz, B., Palmer, M., Stern, A. M., Wagner, B. K., Powers, S., Lowe, S. W., Guo, X., Krasnitz, A., Sawey, E. T., Sordella, R., Stein, L. D., Trotman, L. C., Califano, A., Dalla-Favera, R., Ferrando, A., Iavarone, A., Pasqualucci, L., Silva, J., Stockwell, B. R., Hahn, W. C., Chin, L., DePinho, R. A., Boehm, J. S., Gopal, S., Huang, A., Root, D. E., Weir, B. A., Gerhard, D. S., Zenklusen, J. C., Roth, M. G., White, M. A., Minna, J. D., MacMillan, J. B. , Posner, B. A. (2010) Towards patient-based cancer therapeutics. Nature Biotechnology, 28(9) pp. 904-906.

Trotman, L. C. , Powers, S. (2010) New views into the prostate cancer genome. Cancer Cell, 18(1) pp. 1-2.

Alimonti, A., Carracedo, A., Clohessy, J. G., Trotman, L. C., Nardella, C., Egia, A., Salmena, L., Sampieri, K., Haveman, W. J., Brogi, E., Richardson, A. L., Zhang, J. , Pandolfi, P. P. (2010) Subtle variations in Pten dose determine cancer susceptibility. Nature Genetics, 42(5) pp. 454-458.

Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., Cheng, K., Varmeh, S., Kozma, S. C., Thomas, G., Rosivatz, E., Woscholski, R., Cognetti, F., Scher, H. I. , Pandolfi, P. P. (2010) A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. Journal of Clinical Investigation, 120(3) pp. 681-693.

Janas, M. L., Hodson, D., Stamataki, Z., Hill, S., Welch, K., Gambardella, L., Trotman, L. C., Pandolfi, P. P., Vigorito, E. , Turner, M. (2008) The Effect of Deleting p110{delta} on the Phenotype and Function of PTEN-Deficient B Cells. Journal of Immunology, 180(2) pp. 739-46.

Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., Tempst, P., Chi, S. G., Kim, H. J., Misteli, T., Jiang, X. , Pandolfi, P. P. (2007) Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell, 128(1) pp. 141-56.

Wang, X., Trotman, L. C., Koppie, T., Alimonti, A., Chen, Z., Gao, Z., Wang, J., Erdjument-Bromage, H., Tempst, P., Cordon-Cardo, C., Pandolfi, P. P. , Jiang, X. (2007) NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN. Cell, 128(1) pp. 129-139.

Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C. , Pandolfi, P. P. (2006) Identification of a tumour suppressor network opposing nuclear Akt function. Nature, 441(7092) pp. 523-527.

Chen, Z., Trotman, L. C., Shaffer, D., Lin, H. K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., Cordon-Cardo, C. , Pandolfi, P. P. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature, 436(7051) pp. 725-30.

Strunze, S., Trotman, L. C., Boucke, K. , Greber, U. F. (2005) Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export. Molecular Biology of the Cell, 16(6) pp. 2999-3009.

Steffan, J. S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L. C., Slepko, N., Illes, K., Lukacsovich, T., Zhu, Y. Z., Cattaneo, E., Pandolfi, P. P., Thompson, L. M. , Marsh, J. L. (2004) SUMO Modification of Huntingtin and Huntington's Disease Pathology. Science, 304(5667) pp. 100-104.

Trotman, L. C., Achermann, D. P., Keller, S., Straub, M. , Greber, U. F. (2003) Non-classical export of a adenovirus structural protein. Traffic, 4(6) pp. 390-402.

Trotman, L. C. , Pandolfi, P. P. (2003) PTEN and p53: who will get the upper hand?. Cancer Cell, 3(2) pp. 97-9.

Trotman, L. C., Niki, M., Dotan, Z. A., Koutcher, J. A., Di Cristofano, A., Xiao, A., Khoo, A. S., Roy-Burman, P., Greenberg, N. M., Van Dyke, T., Cordon-Cardo, C. , Pandolfi, P. P. (2003) Pten dose dictates cancer progression in the prostate. PLoS Biology, 1(3)

Trotman, L. C., Mosberger, N., Fornerod, M., Stidwill, R. P. , Greber, U. F. (2001) Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nature Cell Biology, 3(12) pp. 1092-1100.

Stadler, K., Liu, N., Trotman, L. C., Hiltpold, A., Caderas, G., Klauser, S., Hehlgans, T. , Gutte, B. (1995) Design, synthesis, and characterization of HIV-1 enhancer-binding polypeptides derived from bacteriophage 434 repressor. International Journal of Peptide and Protein Research, 46(3-4) pp. 333-340.